Connect Biopharma Limite... (CNTB)
undefined
undefined%
At close: undefined
1.12
0.76%
After-hours Dec 13, 2024, 03:59 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue - - - - -
Cost of Revenue 988.00K 1.03M - - -
Gross Profit -988.00K -1.03M - - -
Operating Income -62.07M -117.66M -99.15M -30.30M -15.99M
Interest Income 5.20K 1.56M 97.67K 109.84K 154.65K
Pretax Income -59.38M -116.12M -204.94M -119.37M -24.46M
Net Income -59.50M -116.42M -205.21M -120.30M -24.02M
Selling & General & Admin 13.53M 20.37M 19.23M 7.31M 1.41M
Research & Development 51.91M 95.26M 81.34M 23.12M 15.44M
Other Expenses -4.35M -940.31K -2.98M -1.07M -411.44K
Operating Expenses 62.07M 114.69M 97.59M 29.36M 16.44M
Interest Expense - 21.03K 6.91K 6.43K 7.69K
Selling & Marketing Expenses 13.51M - - - -
Cost & Expenses 62.07M 114.69M 97.59M 29.36M 16.44M
Income Tax 120.00K 297.52K 266.47K 934.46K -442.49K
Shares Outstanding (Basic) 55.07M 55.04M 52.27M 53.94M 55.82M
Shares Outstanding (Diluted) 55.07M 55.04M 52.27M 53.94M 55.82M
EPS (Basic) -1.08 -14.5 -25 -14.45 -3.02
EPS (Diluted) -1.08 -14.5 -25 -14.45 -3.02
EBITDA -58.37M -111.31M -204.93M -118.21M -24.78M
Depreciation & Amortization 988.00K 1.01M 640.98K 221.05K 114.61K